The GLP-1 Pregnancy Paradox: Stopping Weight-Loss Drugs Linked to Higher Maternal Risks
New research links stopping GLP-1 weight-loss drugs (Ozempic, Wegovy) before pregnancy to higher risks of gestational diabetes and preterm delivery. Learn why discontinuation is required and how to manage the metabolic rebound safely.